Abstract:Recent studies suggest that the epicardium plays an important role in cardiomyogenesis during development, while it becomes quiescent in adult heart. Thymosin beta 4 (Tβ4) has an effect on activating the epicardium. However, effectiveness of Tβ4 administration is unsatisfactory. Therefore, this study prepared cardiac patch and investigated efficiency of activating the epicardium by Tβ4 released sustainedly from the cardiac patch. Mesenchymal stem cells (MSCs) isolated from bone marrow of rats and mice were transfected with Tβ4. Tβ4 release from the cells was determined with an acquity ultra-performance liquid chromatography system. For preparing of cardiac patch, the cells transfected with Tβ4 and Flag were seeded on PLACL/collagen membrane formulated by electrospinning. The survival and proliferation of the cells on the nanofibers were examined after treatment with hypoxia. In MI models of rats and Wt1CreERT2/+, R26mTmG mice, the patches were implanted on the epicardium of the infarcted region. In rat models, differentiation of the epicardium-derived cells (EPDCs) and the engrafted MSCs towards cardiomyocytes and vascular cells was examined by Wt1 immunostaining and Flag labeling. In transgenic mouse models, the activated EPDCs expressed GFP. At four week after implantation of the patches, cardiac function was improved significantly, scar area in the infarcted region was reduced obviously. EPDCs increased in subepicardium and myocardium, and some Wt1+ cells and GFP+ cells expressed CD31, α-SMA or cTnT. Moreover, c-kit+ cells were observed in subepicardium and myocardium, and a few of them expressed CD31, α-SMA or cTnT. Flag labeling showed that some engrafted MSCs migrated into subepicardium and myocardium. These results suggest that Tβ4 released from the transfected MSCs in PLACL/collagen nanofibrous patches may effectively attenuate left ventricular remodeling and improve cardiac function by activating the epicardial cells and recruiting endogenous stem cells. Our finding provides a novel strategy for myocardial regeneration by enhancing the endogenous regenerative mechanisms. References: 1. Guo H D, Cui G H, Wang H J and Tan Y Z (2010) Transplantation of marrow-derived cardiac stem cells carried in designer self-assembling peptide nanofibers improves cardiac function after myocardial infarction. Biochem Bioph Res Co. 399:42–8. 2. Guo H D, Wang H J, Tan Y Z and Wu J H (2011) Transplantation of marrow-derived cardiac stem cells carried in fibrin improves cardiac function after myocardial infarction. Tissue Eng Part A 17:45–58. 3. Kai D, Wang Q L, Wang H J, Prabhakaran M P, Zhang Y Z, Tan Y Z and Ramakrishna S (2014) Stem cell loaded nanofibrous patch promotes regeneration of infarcted myocardium with functional improvement in rat model. Acta Biomaterialia. 10:2727–38. 4. Wang Q L, Wang H J, Li Z H, Wang Y L, Wu X P, Tan Y Z (2017) Mesenchymal stem cell-loaded cardiac patch promotes epicardial activation and repair of the infarcted myocardium.

Thymosin Β4 Promotes the Survival and Angiogenesis of Transplanted Endothelial Progenitor Cells in the Infarcted Myocardium

Thymosin Β4 Promotes Endothelial Progenitor Cell Angiogenesis Via a Vascular Endothelial Growth Factor‑dependent Mechanism.

Safety and efficacy of autologous thymosin β4 pre-treated endothelial progenitor cell transplantation in patients with acute ST segment elevation myocardial infarction: A pilot study.

Thymosin 4 Promotes Glucose-Impaired Endothelial Progenitor Cell Function Via Akt/Endothelial Nitric Oxide Synthesis Signaling Pathway

Thymosin Β4 Reduces Senescence of Endothelial Progenitor Cells Via the PI3K/AKT/eNOS Signal Transduction Pathway

Thymosin Beta 4 Induces Endothelial Progenitor Cell Migration Via Pi3k/Akt/Enos Signal Transduction Pathway

TMSB4 Overexpression Enhances the Potency of Marrow Mesenchymal Stromal Cells for Myocardial Repair.

Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction

Tissue Kallikrein-Modified Human Endothelial Progenitor Cell Implantation Improves Cardiac Function Via Enhanced Activation of Akt and Increased Angiogenesis

Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction

MENSTRUAL BLOOD STEM CELLS IMPROVED MYOCARDIAL SURVIVAL AFTER RAT MYOCARDIAL INFARCTION BY PARACRINE

Intravenous Transfusion of Endothelial Progenitor Cells in Rats with Acute Myocardial Infarction

Thymosin β4 released from functionalized self-assembling peptide activates epicardium and enhances repair of infarcted myocardium

C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.

Transplantation of Endothelial Progenitor Cells in the Treatment of Coronary Artery Microembolism in Rats

Human Umbilical Cord-Derived Endothelial Progenitor Cells Promote Growth Cytokines-Mediated Neorevascularization in Rat Myocardial Infarction.

Enhanced Cytoprotection and Angiogenesis by Bone Marrow Cell Transplantation May Contribute to Improved Ischemic Myocardial Function

Thymosin Beta 4 Treatment after Myocardial Infarction Does Not Reprogram Epicardial Cells into Cardiomyocytes.

Cardiac Patch Loading MSCs Overexpressing TÃÃÂ²4 Promotes Repair of the Infarcted Myocardium by Endogenous Regenerative Mechanisms

Deterioration of cardiac function after acute myocardial infarction is prevented by transplantation of modified endothelial progenitor cells overexpressing endothelial NO synthases.

Endothelial Progenitor Cells Pretreated Ex Vivo with SDF-1 Improve Their Therapeutic Efficiency for Acute Myocardial Infarction